IntroductionHepatic and splenic hemangiomas are common benign tumors that mainly affect female patients. Giant splenic hemangiomas are extremely rare, especially when correlated with multiple hepatic hemangiomas. Pathogenetic mechanisms between hemangiomas and oral contraceptives, as well as therapeutic approaches, are analyzed in this case report, in particular for the management of synchronous splenic and hepatic hemangiomas.Case presentationWe report here a 42-year-old woman with a giant splenic hemangioma, multiple hepatic hemangiomas and a history of oral estrogen intake for many years. At first it was difficult to determine the organ from which the giant hemangioma originated. Angiography proved extremely helpful in tracing its origin in the spleen. Hematomas in the giant hemangioma posed a significant threat of rupture and catastrophic hemorrhage. We left the small hepatic hemangiomas in place, and removed the spleen along with the giant splenic hemangioma.ConclusionDiagnostic pitfalls in the determination of the origin of this giant hemangioma, attribution of its origin to the spleen angiographically, the unusual co-existence of the giant splenic hemangioma with multiple hepatic ones, and the potential threat of rupture of the giant hemangioma are some of the highlights of this case report. Estrogen administration represents a pathogenic factor that has been associated with hemangiomas in solid organs of the abdominal cavity. The therapeutic dilemma between resection and embolization of giant hemangiomas is another point of discussion in this case report. Splenectomy for the giant splenic hemangioma eliminates the risk of rupture and malignant degeneration, whereas observation for the small hepatic ones (<4 cm) was the preferable therapeutic strategy in our patient.
Paleozoic rocks in the Wadi El Sahu area are affected by many major faults in different directions. A reverse fault trending NE‐SW is exposed for about 300 m of its length as it cuts through the Abu Hamata and Adedia formations on the south side of Wadi El Sahu. A secondary ascending hydrothermal solution carrying heavy metals and radioactive minerals passed through the fault plain and the surrounding fractures, forming mineralized and radioactive zone. The mineralized zone thickness ranges from 60 cm to 200 cm along the fault plain. These rocks were analyzed radiometrically using a portable gamma‐ray spectrometer, chemically by employing ICP‐ES and ICP‐MS, as well as mineralogically by both binocular and Environmental Scanning Electron microscope. Gold content was also determined by fire assay. REE and U contents reached up to 2682 and 1216 ppm, respectively. Mineralogical investigations indicated the presence of uraninite, torbernite, autunite, sklodowskite, kasolite as uranium minerals, thorite as a thorium mineral, monazite, allanite and xenotime as REE‐bearing minerals, zircon and columbite as accessory minerals, gold and nickel as precious and base metals, in addition to cassiterite, chalcopyrite, chalcocite and chrysocolla. High REE and U contents are attributed to the circulation of epigenetic U and REE‐bearing hydrothermal solutions along the fault plain and its surrounding fractures. Hydrothermal alteration processes could then be confirmed by the presence of the M‐type tetrad effect in the REE‐patterns of the ferruginous sandstone. The non‐chondritic ratio of Nb/Ta, Zr/Hf and Y/Ho in the studied sandstone may be attributed to the tetrad effect. The Ce and Eu anomaly with unusual REE‐patterns was represented by the presence of conjugated M‐W tetrad effects, indicating either the dual effect of hydrothermal solutions or groundwater with seawater. The results clarify that the tetrad‐effects could be used as evidence for the environment of deposition and as an indication for gold mineralization.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.